NFS1 and colorectal carcinoma: The loss of NFS1 combined with oxaliplatin treatment caused PANoptosis by enhancing the intracellular expression levels of reactive oxygen species (ROS) [60], indicating that NFS1 is a negative regulator of PANoptosis in CRC.